分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Microglial Piezo1 senses Aβ fibril stiffness to restrict Alzheimer’s disease

Jin Hu, Qiang Chen, Hongrui Zhu, Lichao Hou, Wei Liu, Qihua Yang, Huidan Shen, Guolin Chai, Boxin Zhang, Shaoxuan Chen, Zhiyu Cai, Chongxin Wu, Fan Hong, Hongda Li, Sifang Chen, Naian Xiao, Zhan-xian

Journal:NEURON

IF:18.69

DOI:10.1016/j.neuron.2022.10.021

PMID:36368316

Published:2022-11-10

research field:神经科学细胞生物学病理学

Abstract

Summary The pathology of Alzheimer’s disease (AD) is featured with extracellular amyloid-β (Aβ) plaques, whose impact on the mechanical properties of the surrounding brain tissues is unclear. Microglia sense and integrate biochemical cues of the microenvironment. However, whether the microglial mechanosensing pathways influence AD pathogenesis is unknown. Here, we surveyed the elevated stiffness of Aβ-plaque-associated tissues and observed the selective upregulation of the mechanosensitive ion channel Piezo1 in Aβ-plaque-associated microglia. Piezo1 sensed the stiffness stimuli of Aβ fibrils and subsequently induced Ca 2+ influx for microglial clustering, phagocytosis , and compacting of Aβ plaques. Microglia lacking Piezo1 led to the exacerbation of Aβ pathology and cognitive decline, whereas pharmacological activation of microglial Piezo1 ameliorated brain Aβ burden and cognitive impairment in 5 ×  FAD mice. Together, our results reveal that Piezo1, a mechanosensor of Aβ fibril stiffness in microglia, represents a potential therapeutic target for AD.

本文使用的Yeasen产品

购物车
客服
转染试用